Mass Spectrometry and Proteomics featured on the 2018 issue of Breakthoughs – the year in review for

Mass Spectrometry and Proteomics: Powerful Tools for Cancer Research

(Credit to “Peter Baker Photography”)

Advances in mass spectrometry and proteomics

are giving researchers new ways to better understand,

detect, diagnose, and treat cancer. A year ago, Yale

recruited Yansheng Liu, PhD, Assistant Professor of

Pharmacology, to bring these innovative tools to the

Cancer Biology Institute.

Dr. Liu arrived from Zurich, Switzerland, where he

spent more than six years in the Proteomics Lab of

Dr. Ruedi Aebersold, a world-renowned pioneer in

proteomics. He was lured here in part by Yale’s offer to

furnish his laboratory with the fastest and most versatile

mass spectrometer available, an Orbitrap Fusion Lumos,

which Dr. Liu calls essential for his next-generation

proteomics research.

See the whole article below

https://www.yalecancercenter.org/research/programs/transduction/ST%202018_349761_1090_12436_v1.pdf